1. ICD-10-CM Codes
›
2. E00-E89
›
3. E20-E35
›
4. E34-
›
5. 2023 ICD-10-CM Diagnosis Code E34.51

2023 ICD-10-CM Diagnosis Code E34.51

Complete androgen insensitivity syndrome

2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code

• E34.51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
• The 2023 edition of ICD-10-CM E34.51 became effective on October 1, 2022.
• This is the American ICD-10-CM version of E34.51 - other international versions of ICD-10 E34.51 may differ.

• Testicular feminization

• A disorder also known as complete androgen insensitivity syndrome (cais). The 46,xy genetic male totally lacks androgen responsiveness in the target organs thus exhibits a female phenotype.
• A disorder of sexual development in persons with 46xy karyotype, characterized by an abnormality of the genes encoding androgen receptors. It results in a female sex appearance or the development of both male and female characteristics.
• Aspects of female morphology in a xy genotype caused by defects in cellular receptors for testosterone and dihydrotestosterone, transmitted as an x-linked trait.
• Sexual ambiguity in males due to a sexual differentiation disorder caused by testicular failure to respond to androgens. The affected males have abdominal and inguinal testes, female external genitalia and breasts, blind vaginas, and absent uteri. Some patients have absent pubic and axillary hair, hence the synonym "hairless pseudofemale." mental retardation occurs in some cases.

• 643 Endocrine disorders with mcc
• 644 Endocrine disorders with cc
• 645 Endocrine disorders without cc/mcc

Convert E34.51 to ICD-9-CM

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change
• 2023 (effective 10/1/2022): No change

• De Quervain's
  • syndrome E34.51
• Goldberg-Maxwell syndrome E34.51
• Insensitivity
  • androgen E34.50
    ICD-10-CM Diagnosis Code E34.50

    Androgen insensitivity syndrome, unspecified

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code

    Applicable To

    • Androgen insensitivity NOS
    • complete E34.51
• Pseudohermaphroditism Q56.3
  ICD-10-CM Diagnosis Code Q56.3

  Pseudohermaphroditism, unspecified

  2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
  • male Q56.1
    - see also Disorder, adrenogenital
    ICD-10-CM Diagnosis Code Q56.1

    Male pseudohermaphroditism, not elsewhere classified

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Male Dx POA Exempt

    Applicable To

    • 46, XY with streak gonads
    • Male pseudohermaphroditism NOS
    • with
      • androgen resistance E34.51
      • feminizing testis E34.51
• Syndrome - see also Disease
  • androgen insensitivity E34.50
    ICD-10-CM Diagnosis Code E34.50

    Androgen insensitivity syndrome, unspecified

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code

    Applicable To

    • Androgen insensitivity NOS
    • complete E34.51
  • De Quervain E34.51
  • Goldberg-Maxwell E34.51
  • testicular feminization E34.51 - see also Syndrome, androgen insensitivity
• Testicle, testicular, testis - see also condition
  • feminization syndrome E34.51 - see also Syndrome, androgen insensitivity

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.